Found 9971 bookmarks
Newest
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study - PubMed
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study - PubMed
In this real-world study conducted in Germany, CDI was associated with increased risk of death and substantial costs to health systems due to higher HCRU, especially hospitalisations. HCRU and associated costs were exacerbated by rCDIs.
·pubmed.ncbi.nlm.nih.gov·
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study - PubMed
Does the Surgical Approach Affect the Incidence of Post-Hepatectomy Liver Failure in Cirrhotic Patients? An Analysis of the NSQIP Database - PubMed
Does the Surgical Approach Affect the Incidence of Post-Hepatectomy Liver Failure in Cirrhotic Patients? An Analysis of the NSQIP Database - PubMed
Background: The association between surgical approach and post-hepatectomy liver failure (PHLF) in cirrhotic patients is poorly understood. We hypothesize that patients will have similar rates of liver failure regardless of whether they undergo minimally invasive liver resection (MILR) or ope …
·pubmed.ncbi.nlm.nih.gov·
Does the Surgical Approach Affect the Incidence of Post-Hepatectomy Liver Failure in Cirrhotic Patients? An Analysis of the NSQIP Database - PubMed
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches - PubMed
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches - PubMed
Clostridioides difficile (C. difficile), as the major pathogen of diarrhea in healthcare settings, has become increasingly prevalent within community populations, resulting in significant morbidity and mortality. However, the therapeutic options for Clostridioides difficile infe …
·pubmed.ncbi.nlm.nih.gov·
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches - PubMed
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches - PubMed
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches - PubMed
Clostridioides difficile (C. difficile), as the major pathogen of diarrhea in healthcare settings, has become increasingly prevalent within community populations, resulting in significant morbidity and mortality. However, the therapeutic options for Clostridioides difficile infe …
·pubmed.ncbi.nlm.nih.gov·
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches - PubMed
Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report - PubMed
Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report - PubMed
Intestinal microecological transplantation is an effective treatment for relieving the clinical symptoms of chronic radiation enteritis by altering the composition of the intestinal flora. This study provides a new approach for treating patients with chronic radiation enteritis.
·pubmed.ncbi.nlm.nih.gov·
Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report - PubMed
Microbiota treatment of functional constipation: Current status and future prospects - PubMed
Microbiota treatment of functional constipation: Current status and future prospects - PubMed
Functional constipation (FC) is a common disorder that is characterized by difficult stool passage, infrequent bowel movement, or both. FC is highly prevalent, recurs often, accompanies severe diseases, and affects quality of life; therefore, safe and effective therapy with long-term benefits is urg …
·pubmed.ncbi.nlm.nih.gov·
Microbiota treatment of functional constipation: Current status and future prospects - PubMed
Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective - PubMed
Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective - PubMed
Due to its complex pathogenesis, treatment of hepatic encephalopathy (HE) continues to be a therapeutic challenge. Of late, gut microbiome has garnered much attention for its role in the pathogenesis of various gastrointestinal and liver diseases and its potential therapeutic use. New evidence sugge …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective - PubMed
A Gram-negative-selective antibiotic that spares the gut microbiome - PubMed
A Gram-negative-selective antibiotic that spares the gut microbiome - PubMed
Infections caused by Gram-negative pathogens are increasingly prevalent and are typically treated with broad-spectrum antibiotics, resulting in disruption of the gut microbiome and susceptibility to secondary infections1-3. There is a critical need for antibiotics that are selective both …
·pubmed.ncbi.nlm.nih.gov·
A Gram-negative-selective antibiotic that spares the gut microbiome - PubMed
Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection - PubMed
Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection - PubMed
Clostridioides difficile has emerged as a major cause of life-threatening diarrheal disease. Conventional antibiotics used in current standards of care exacerbate the emergence of antibiotic-resistant strains and pose a risk of recurrent C. difficile infection (CDI). Thus, there is an urgent need fo …
·pubmed.ncbi.nlm.nih.gov·
Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection - PubMed
Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus - PubMed
Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus - PubMed
Our study fills this knowledge gap by finding that alterations in gut microbiota have an independent impact on hyperglycemia and insulin resistance in the GDM state. In vivo and in vitro, gut dysbiosis is linked to adipose tissue inflammation and insulin resistance via the bacterial product SCFAs in …
·pubmed.ncbi.nlm.nih.gov·
Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus - PubMed
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy - PubMed
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy - PubMed
The use of rifaximin significantly reduces infections in patients with cirrhosis and HE. Despite rifaximin was associated with a decreased all-cause mortality, this impact was not statistically significant in the adjusted analysis.
·pubmed.ncbi.nlm.nih.gov·
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy - PubMed
Molecular Characterization and Potential Host-switching of Swine Farm associated Clostridioides difficile ST11 - PubMed
Molecular Characterization and Potential Host-switching of Swine Farm associated Clostridioides difficile ST11 - PubMed
Swine farm associated C. difficile ST11 carried fewer virulence genes than ST11 strains collected from NCBI database. It is critical to monitor the evolution of C. difficile strains to understand their changing characteristics, host-switching, and develop effective control and prevention strategies.
·pubmed.ncbi.nlm.nih.gov·
Molecular Characterization and Potential Host-switching of Swine Farm associated Clostridioides difficile ST11 - PubMed
Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016 - PubMed
Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016 - PubMed
Ten Clostridioides difficile isolates representing the top 10 ribotypes collected in 2016 through the Emerging Infections Program underwent long-read sequencing to obtain high-quality reference genome assemblies. These isolates are publicly available through the CDC & FDA Antibiotic Resis …
·pubmed.ncbi.nlm.nih.gov·
Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016 - PubMed
Clostridium Difficile Infections Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Novartis AG, Astellas Pharma, Eli Lilly & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co. Inc., Ba
Clostridium Difficile Infections Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Novartis AG, Astellas Pharma, Eli Lilly & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co. Inc., Ba
Las Vegas Nevada United States As per DelveInsight s assessment globally Clostridium Difficile Infections pipeline constitutes 20 key companies continuously working towards developing 22 Clostridium Difficile Infections treatment therapies analysis of Clinical Trials Therapies Mechanism of Action Route of Administration ...
·news.google.com·
Clostridium Difficile Infections Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Novartis AG, Astellas Pharma, Eli Lilly & Company AstraZeneca, Actelion Pharmaceuticals Ltd., Merck & Co. Inc., Ba
Clostridium Difficile Diagnostics And Treatment Market Global Size, Market Share, Opportunities, Industry Analysis, and Forecast to 2031| Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc
Clostridium Difficile Diagnostics And Treatment Market Global Size, Market Share, Opportunities, Industry Analysis, and Forecast to 2031| Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc
Market Overview Clostridium difficile infections are a major cause of hospital acquired diarrhea particularly among older patients receiving antibiotic treatment during a hospital stay Diagnostic tests are used to detect presence of Clostridium difficile bacteria and toxins to confirm diagnosis ...
·news.google.com·
Clostridium Difficile Diagnostics And Treatment Market Global Size, Market Share, Opportunities, Industry Analysis, and Forecast to 2031| Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc
Alginate oligosaccharide-mediated butyrate-HIF-1α axis improves skin aging in mice - PubMed
Alginate oligosaccharide-mediated butyrate-HIF-1α axis improves skin aging in mice - PubMed
The "gut-skin" axis has been proved and is considered as a novel therapy for the prevention of skin aging. The antioxidant efficacy of oligomannonic acid (MAOS) make it an intriguing target for use to improve skin aging. The present study further explored whereby MAOS-mediated gut-skin axis balance …
·pubmed.ncbi.nlm.nih.gov·
Alginate oligosaccharide-mediated butyrate-HIF-1α axis improves skin aging in mice - PubMed
Novel therapeutic strategy for obesity through the gut microbiota-brain axis: A review article - PubMed
Novel therapeutic strategy for obesity through the gut microbiota-brain axis: A review article - PubMed
Background: The interaction between commensal bacteria and the host is essential for health and the gut microbiota-brain axis plays a vital role in this regard. Obesity as a medical problem not only affect the health of the individuals, but also the economic and social aspects of communities. …
·pubmed.ncbi.nlm.nih.gov·
Novel therapeutic strategy for obesity through the gut microbiota-brain axis: A review article - PubMed
Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study - PubMed
Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study - PubMed
Fidaxomicin treated patients had statistically increased odds of rCDI. Compared to other treatments, fidaxomicin was inferior to metronidazole for rCDI in our cohort;Hypervirulent C. difficile was not associated with death.Vancomycin resistance of C. difficile statistically decreased, …
·pubmed.ncbi.nlm.nih.gov·
Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study - PubMed
NHH promotes Sepsis-associated Encephalopathy with the expression of AQP4 in astrocytes through the gut-brain Axis - PubMed
NHH promotes Sepsis-associated Encephalopathy with the expression of AQP4 in astrocytes through the gut-brain Axis - PubMed
Sepsis-associated encephalopathy (SAE) is a significant cause of mortality in patients with sepsis. Despite extensive research, its exact cause remains unclear. Our previous research indicated a relationship between non-hepatic hyperammonemia (NHH) and SAE. This study aimed to investigate the relati …
·pubmed.ncbi.nlm.nih.gov·
NHH promotes Sepsis-associated Encephalopathy with the expression of AQP4 in astrocytes through the gut-brain Axis - PubMed